Beyond Air to Participate in the D. Boral Capital Global Conference 2026
Beyond Air, Inc., a NASDAQ-listed commercial-stage medical device and biopharmaceutical company specializing in nitric oxide therapies, announced that its CEO and CFO will participate in the D. Boral Capital Global Conference on May 7, 2026. The company highlights its LungFit PH system, FDA and CE approved for treating neonates with hypoxic respira…